Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats.

Mehraein F, Talebi R, Jameie B, Joghataie MT, Madjd Z.

Iran Biomed J. 2011;15(1-2):44-50.

2.

[Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].

Meng JL, Ma YY, Luo HY, Kong SZ, He YW, Dong BC, Wu SH, He M.

Sheng Li Xue Bao. 2008 Jun 25;60(3):369-74. Chinese.

3.
4.

Influence of aging on the dopaminergic neurons in the substantia nigra pars compacta of rats.

Gao J, Miao H, Xiao CH, Sun Y, Du X, Yuan HH, Yu HL, Gao DS.

Curr Aging Sci. 2011 Feb;4(1):19-24.

PMID:
21204780
6.

Failure of estrogen to protect the substantia nigra pars compacta of female rats from lesion induced by 6-hydroxydopamine.

Ferraz AC, Xavier LL, Hernandes S, Sulzbach M, Viola GG, Anselmo-Franci JA, Achaval M, Da Cunha C.

Brain Res. 2003 Oct 3;986(1-2):200-5.

PMID:
12965246
7.

Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.

Ueda S, Sakakibara S, Nakadate K, Noda T, Shinoda M, Joyce JN.

Neurosci Lett. 2005 Jun 3;380(3):252-6. Epub 2005 Feb 8.

PMID:
15862896
8.

Does melatonin help save dopaminergic cells in MPTP-treated mice?

Ma J, Shaw VE, Mitrofanis J.

Parkinsonism Relat Disord. 2009 May;15(4):307-14. doi: 10.1016/j.parkreldis.2008.07.008. Epub 2008 Sep 14.

PMID:
18793863
9.

[Sexual dimorphisms of dopaminergic neurons in rat substantia nigra].

Ma YY, Kong SZ, Yang LJ, Meng JL, Lv LC, He M.

Sheng Li Xue Bao. 2007 Dec 25;59(6):753-8. Chinese.

10.

Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.

Gui ZH, Liu J, Wang Y, Ali U, Wang T, Chen L.

Chin J Physiol. 2011 Apr 30;54(2):96-104. Erratum in: Chin J Physiol. 2011 Jun 30;54(3):203.

PMID:
21789890
11.

N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.

Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P.

Brain Res. 2000 Mar 24;859(2):286-92.

PMID:
10719076
12.

The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.

Panneton WM, Kumar VB, Gan Q, Burke WJ, Galvin JE.

PLoS One. 2010 Dec 13;5(12):e15251. doi: 10.1371/journal.pone.0015251. Erratum in: PLoS One. 2011;6(2). doi: 10.1371/annotation/819cbf4a-7e3e-4e4e-a449-b667bc6e8957.

13.

Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats.

Capitelli C, Sereniki A, Lima MM, Reksidler AB, Tufik S, Vital MA.

Eur J Pharmacol. 2008 Oct 10;594(1-3):101-8. doi: 10.1016/j.ejphar.2008.07.022. Epub 2008 Jul 17.

PMID:
18674531
14.

Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system.

Kim YS, Joo WS, Jin BK, Cho YH, Baik HH, Park CW.

Neuroreport. 1998 Jul 13;9(10):2387-90.

PMID:
9694233
15.

Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.

Liu LX, Chen WF, Xie JX, Wong MS.

Neurosci Res. 2008 Feb;60(2):156-61. Epub 2007 Oct 23.

PMID:
18054104
16.

Neuroprotective effects of pramipexole in young and aged MPTP-treated mice.

Anderson DW, Neavin T, Smith JA, Schneider JS.

Brain Res. 2001 Jun 29;905(1-2):44-53.

PMID:
11423078
17.

The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.

Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, Dexter DT.

J Pharm Pharmacol. 2004 May;56(5):649-54.

PMID:
15142343
18.

Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.

Porritt MJ, Batchelor PE, Howells DW.

Exp Neurol. 2005 Mar;192(1):226-34.

PMID:
15698637
19.

[The protective effect of ginsenoside Rg1 on dopaminergic neurons of substantia in the ovariectomized rat model of Parkinson's disease].

Xu L, Liu LX, Chen WF, Xie JX, Huang WX.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2008 Feb;24(1):1-5. Chinese.

PMID:
21141541

Supplemental Content

Support Center